IDEXX LABORATORIES INC /DE Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of $8.63 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2018-08-01
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2018-06-30 was $8.63M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2018-03-31 was -$803.00K.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2017-12-31 was -$1.08M, a 121.21% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2017-09-30 was -$2.53M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2017 was -$10.13M, a 475.51% decline from fiscal 2016.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2016 was $2.70M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2015 was -$5.14M, a 168.21% decline from fiscal 2014.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2014 was $7.54M, a 298.73% increase from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month |
|---|---|---|---|---|
| 2018-06-30 | $8.63M 10-Q · filed 2018-08-01 | $7.83M 10-Q · filed 2018-08-01 | $6.75M derived: sum of 3 quarters · filed 2018-08-01 | $4.22M derived: sum of 4 quarters · filed 2018-08-01 |
| 2018-03-31 | -$803.00K 10-Q · filed 2018-05-04 | -$1.88M derived: sum of 2 quarters · filed 2018-05-04 | -$4.41M derived: sum of 3 quarters · filed 2018-05-04 | -$8.73M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$3.61M derived: sum of 2 quarters · filed 2018-02-16 | -$7.93M derived: sum of 3 quarters · filed 2018-08-01 | -$10.13M 10-K · filed 2018-02-16 |
| 2017-09-30 | -$2.53M 10-Q · filed 2017-10-31 | -$6.85M derived: sum of 2 quarters · filed 2018-08-01 | -$9.06M 10-Q · filed 2017-10-31 | -$3.99M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-06-30 | -$4.32M 10-Q · filed 2018-08-01 | -$6.53M 10-Q · filed 2018-08-01 | -$1.46M derived: sum of 3 quarters · filed 2018-08-01 | -$2.04M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | -$2.21M 10-Q · filed 2018-05-04 | $2.87M derived: sum of 2 quarters · filed 2018-05-04 | $2.29M derived: sum of 3 quarters · filed 2018-05-04 | $4.19M derived: sum of 4 quarters · filed 2018-05-04 |
| 2016-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $4.49M derived: sum of 2 quarters · filed 2018-02-16 | $6.39M derived: sum of 3 quarters · filed 2018-02-16 | $2.70M 10-K · filed 2018-02-16 |
| 2016-09-30 | -$580.00K 10-Q · filed 2017-10-31 | $1.32M derived: sum of 2 quarters · filed 2017-10-31 | -$2.37M 10-Q · filed 2017-10-31 | -$4.63M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $1.90M 10-Q · filed 2017-08-01 | -$1.79M 10-Q · filed 2017-08-01 | -$4.05M derived: sum of 3 quarters · filed 2018-02-16 | -$4.92M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | -$3.69M 10-Q · filed 2017-04-28 | -$5.95M derived: sum of 2 quarters · filed 2018-02-16 | -$6.82M derived: sum of 3 quarters · filed 2018-02-16 | -$13.06M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$3.13M derived: sum of 2 quarters · filed 2018-02-16 | -$9.36M derived: sum of 3 quarters · filed 2018-02-16 | -$5.14M 10-K · filed 2018-02-16 |
| 2015-09-30 | -$874.00K 10-Q · filed 2016-11-01 | -$7.11M derived: sum of 2 quarters · filed 2016-11-01 | -$2.89M 10-Q · filed 2016-11-01 | $728.00K derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$6.24M 10-Q · filed 2016-08-02 | -$2.01M 10-Q · filed 2016-08-02 | $1.60M derived: sum of 3 quarters · filed 2017-02-17 | $7.60M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $4.22M 10-Q · filed 2016-04-29 | $7.84M derived: sum of 2 quarters · filed 2017-02-17 | $13.84M derived: sum of 3 quarters · filed 2017-02-17 | $12.16M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $9.62M derived: sum of 2 quarters · filed 2017-02-17 | $7.94M derived: sum of 3 quarters · filed 2017-02-17 | $7.54M 10-K · filed 2017-02-17 |
| 2014-09-30 | $6.00M 10-Q · filed 2015-10-28 | $4.33M derived: sum of 2 quarters · filed 2015-10-28 | $3.92M 10-Q · filed 2015-10-28 | $4.23M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | -$1.67M 10-Q · filed 2015-07-30 | -$2.08M 10-Q · filed 2015-07-30 | -$1.76M derived: sum of 3 quarters · filed 2016-02-17 | -$6.20M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | -$402.00K 10-Q · filed 2015-04-28 | -$92.00K derived: sum of 2 quarters · filed 2016-02-17 | -$4.53M derived: sum of 3 quarters · filed 2016-02-17 | -$2.62M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | -$4.13M derived: sum of 2 quarters · filed 2016-02-17 | -$2.22M derived: sum of 3 quarters · filed 2016-02-17 | $1.89M 10-K · filed 2016-02-17 |
| 2013-09-30 | -$4.43M 10-Q · filed 2014-10-24 | -$2.53M derived: sum of 2 quarters · filed 2014-10-24 | $1.58M 10-Q · filed 2014-10-24 | $1.83M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $1.91M 10-Q · filed 2014-07-25 | $6.02M 10-Q · filed 2014-07-25 | $6.26M derived: sum of 3 quarters · filed 2015-02-17 | $2.71M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $4.11M 10-Q · filed 2014-04-25 | $4.36M derived: sum of 2 quarters · filed 2015-02-17 | $799.00K derived: sum of 3 quarters · filed 2015-02-17 | $533.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$3.31M derived: sum of 2 quarters · filed 2015-02-17 | -$3.58M derived: sum of 3 quarters · filed 2015-02-17 | -$5.28M 10-K · filed 2015-02-17 |
| 2012-09-30 | -$3.56M 10-Q · filed 2013-10-22 | -$3.82M derived: sum of 2 quarters · filed 2013-10-22 | -$5.52M 10-Q · filed 2013-10-22 | -$4.40M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | -$266.00K 10-Q · filed 2013-07-23 | -$1.97M 10-Q · filed 2013-07-23 | -$848.00K derived: sum of 3 quarters · filed 2014-02-18 | $4.42M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | -$1.70M 10-Q · filed 2013-04-23 | -$582.00K derived: sum of 2 quarters · filed 2014-02-18 | $4.68M derived: sum of 3 quarters · filed 2014-02-18 | $6.14M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $6.39M derived: sum of 2 quarters · filed 2014-02-18 | $7.84M derived: sum of 3 quarters · filed 2014-02-18 | $5.76M 10-K · filed 2014-02-18 |
| 2011-09-30 | $5.27M 10-Q · filed 2012-10-19 | $6.72M derived: sum of 2 quarters · filed 2012-10-19 | $4.64M 10-Q · filed 2012-10-19 | |
| 2011-06-30 | $1.45M 10-Q · filed 2012-07-20 | -$623.00K 10-Q · filed 2012-07-20 | ||
| 2010-12-31 | $730.00K 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |